Dr. Reddy is a principal investigator in the ongoing SynerFuse feasibility study, according to a May 15 news release shared with Becker’s. He and Dr. Falowski are also strategic advisors to the company.
SynerFuse develops devices to address back pain associated with spinal fusion.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
